Article Text

other Versions

PDF
No association between losartan use and acute pancreatitis in hypertensive patients
  1. Shih-Wei Lai1,2,
  2. Hsien-Feng Lin2,3,
  3. Cheng-Li Lin1,4,
  4. Kuan-Fu Liao5,6,7
  1. 1College of Medicine, China Medical University, Taichung, Taiwan
  2. 2Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan
  3. 3School of Chinese Medicine, China Medical University, Taichung, Taiwan
  4. 4Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan
  5. 5College of Medicine, Tzu Chi University, Hualien, Taiwan
  6. 6Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan
  7. 7Department of Internal Medicine, Taichung Tzu Chi General Hospital, Taichung, Taiwan
  1. Correspondence to Dr Kuan-Fu Liao, Department of Internal Medicine, Taichung Tzu Chi General Hospital, No 66, Sec. 1, Fongsing Road, Tanzi District, Taichung City 427, Taiwan; kuanfuliaog{at}gmail.com

Abstract

Background and objective Clinical evidence is scarce about the relationship between losartan use and acute pancreatitis. We therefore conducted a population-based case–control study using the database from the Taiwan National Health Insurance Program to investigate this question.

Methods The study consisted of 1449 hypertensive subjects aged 20–84 years with a first episode of acute pancreatitis during the period 2000–2011 as the case group and 2479 hypertensive subjects without acute pancreatitis as the control group. Both the case and control groups were matched for sex, age, comorbidities and index year of acute pancreatitis diagnosis. According to the history of losartan prescription before the date of diagnosis of acute pancreatitis, subjects who had never received a prescription for losartan were defined as ‘never use of losartan’, those whose last remaining losartan tablet was detected within 7 days before the date of diagnosis of acute pancreatitis were defined as ‘current use of losartan’ and those whose last remaining tablet of losartan was detected ≥8 days before the date of diagnosis of acute pancreatitis were defined as ‘late use of losartan’. ORs and 95% CIs were measured to investigate the risk of acute pancreatitis associated with losartan use by the multivariable unconditional logistic regression model.

Results After adjustment for potentially confounding factors, the adjusted OR of acute pancreatitis was 0.96 (95% CI 0.68 to 1.37) for subjects with current use of losartan compared with those with never use of losartan, but the difference was not statistically significant. For subjects with late use of losartan the adjusted OR of acute pancreatitis was 1.05 (95% CI 0.80 to 1.37), which also was not statistically significant.

Conclusions No significant association can be detected between losartan use and acute pancreatitis in hypertensive patients. More research is required to determine the potential role of losartan in the risk of acute pancreatitis.

  • losartan
  • acute pancreatitis
  • biliary stone
  • alcohol
View Full Text

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.